SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to widespread anticipation surrounding the outcome of a recent FDA meeting concerning its lead drug, Sonelokimab, for Hidradenitis Suppurativa. The community largely expects a positive regulatory update, which many believe would significantly de-risk the asset. This has intensified discussions about a potential acquisition by a major pharmaceutical player, fueled by reported prior interest and recent executive share conversions interpreted by some as preparatory for a substantial transaction.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is generating intense buzz ahead of its highly anticipated BlueBird 6 satellite launch, which is viewed as a pivotal moment for its space-based cellular network deployment. The community is sharply divided, with fervent bulls anticipating substantial gains post-launch, while bears warn of an overvalued stock and a potential "sell the news" event. This dichotomy is fueling significant conversation and market volatility around the company's future in satellite communications.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending due to anticipation surrounding its showcase of commercial quantum computing solutions and real-world applications at an upcoming major tech event, fueling speculation about its "quantum supremacy" in optimization. The community is actively debating its potential as a generational technology, drawing comparisons to early AI, while skeptics point to its current low revenue, cash burn, and perceived overvaluation amidst allegations of manipulated "pump and dump" cycles.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending amid strong community buzz surrounding its upcoming merger with Infleqtion, a quantum technology leader. Investors are highlighting Infleqtion's established partnerships with defense and aerospace entities, along with its commercially viable quantum sensing and timing solutions, which many believe are significantly undervalued compared to sector peers. The sentiment suggests anticipation for substantial institutional investment and accelerated growth once the ticker changes post-merger.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is experiencing extreme volatility following its recent IPO, igniting intense community debate. Bulls highlight its low float and aerospace sector exposure as potential catalysts for a massive squeeze, while skeptics label it a pump-and-dump, raising concerns about its valuation, pre-revenue status, and the qualifications of its R&D team. The stock's dramatic price swings and unusually high short borrow fees are central to the ongoing, heated discussion.

TOSHI

TOSHI is a trending topic, with its community deeply engaged in discussions around its role as the "Face of Base" blockchain following recent listings on major exchanges and a Coinbase One collaboration. Despite recent market volatility, the "blue cat" faithful are actively accumulating, anticipating future growth and potential listings on platforms like Robinhood or Binance, highlighting strong long-term conviction.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is seeing intense bullish momentum, with spot silver prices reaching new all-time highs, driven by tightening global supply due to upcoming Chinese export restrictions and surging industrial demand from sectors like EVs, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is a trending topic, actively debated by the community, driven by its pivotal role in US LNG exports and strategic moves in a shifting global energy landscape. Bulls see it as deeply undervalued with strong operational performance and significant long-term growth potential, fueled by Europe's pivot from Russian gas and recent competitive developments. However, ongoing arbitration cases and recent analyst downgrades continue to generate concern and mixed sentiment regarding near-term price action.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as gold prices reach new all-time highs, fueled by geopolitical concerns and growing anticipation of significant central bank liquidity injections and rate cuts. Community chatter highlights a divergence in sentiment, with many celebrating gold's role as a critical safe haven and hedge against fiat debasement, while others warn of a speculative bubble and an imminent "violent correction." This rise is widely interpreted as a signal of deep macroeconomic uncertainty, with discussions often framing it as a "currency reset" and a rotation into tangible assets amid global debt concerns.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending with intense anticipation surrounding a pivotal FDA decision for its drug Narsoplimab (Yartemlea) by December 26th, targeting a life-threatening condition without an approved treatment. This binary event is bolstered by the recent closing of a significant deal with Novo Nordisk, bringing in substantial upfront cash and potential future milestones, along with a $100 million share repurchase program, fueling community expectations for a transformative approval and a notable short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 8,805 shares of Pulmonx stock in a transaction dated Monday, December 1st. The shares were sold at an average price of...

Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) General Counsel David Aaron Lehman sold 10,278 shares of the firm's stock in a transaction on Monday, December 1st. The shares were sold at an...

Insider Selling: Pulmonx (NASDAQ:LUNG) CEO Sells 8,805 Shares of Stock

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 8,805 shares of the firm's stock in a transaction dated Monday, December 1st. The shares were sold at an average price...

Pulmonx Corporation $LUNG Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA trimmed its position in shares of Pulmonx Corporation (NASDAQ:LUNG - Free Report) by 4.6% in the second quarter, according to its most recent filing with the Securities and...

Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Pulmonx from a "sell" rating to a "hold" rating in a report on Sunday...

Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital

D. Boral Capital reiterated a "buy" rating and set a $14.00 price target on shares of Pulmonx in a research note on Thursday...

Pulmonx (NASDAQ:LUNG) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Pulmonx (NASDAQ:LUNG - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.40) by $0.06. The...

Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates

Pulmonx (LUNG) delivered earnings and revenue surprises of +15.00% and +4.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Pulmonx's Earnings: A Preview

Pulmonx Corporation (NASDAQ:LUNG) Receives Average Recommendation of "Hold" from Analysts

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average recommendation of "Hold" from the ten brokerages that are presently covering the company, MarketBeat.com reports. One...

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.40	--	--	N/A
Q3 '25	-$0.42	-$0.34	19.43%	BEAT
Q2 '25	-$0.40	-$0.38	5.39%	BEAT
Q1 '25	-$0.40	-$0.36	9.97%	BEAT
Q4 '24	-$0.45	-$0.33	26.25%	BEAT

LUNG
Pulmonx Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest LUNG News

LUNGPulmonx Corp